Physician profile
Toussaint Smith
NPI 1902843949
$12,023.98
in general payments reported to CMS, 2019-2025
48 companies · $1,938 in 2025
The $1,938 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $1,084 · 2021: $1,105 · 2022: $1,409 · 2023: $2,479 · 2024: $2,253 · 2025: $1,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,670.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,152.78 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $1,136.44 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $1,110.17 | 2019-2025 | Leqvio |
| Amgen INC. | $986.72 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $799.61 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $773.24 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $684.12 | 2019-2025 | Farxiga, Wainua |
| Boston Scientific Corporation | $567.77 | 2019-2025 | Watchman Flx, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $520.74 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $517.87 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $480.99 | 2021-2025 | Jardiance |
| Medtronic, INC. | $372.70 | 2021-2025 | Corevalve Evolut R, Harmony |
| Irhythm Technologies, INC. | $335.00 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $281.03 | 2023-2024 | Optimizer, Optimizer |
| Actelion Pharmaceuticals US, INC. | $265.62 | 2019-2025 | Opsumit, Uptravi |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $242.62 | 2019-2025 | Cardiomems, Confirm Rx, Thoratec Heartmate 3 Lvas Implant Kit |
| Scpharmaceuticals INC. | $158.03 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $155.02 | 2024 | Arcalyst |
| Heartflow, INC. | $119.89 | 2019-2024 | |
| Novo Nordisk INC | $112.67 | 2024-2025 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $104.37 | 2020-2025 | Nexletol |
| Astellas Pharma US INC | $92.04 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $87.73 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $85.09 | 2019-2021 | |
| Cardiva Medical, INC. | $81.67 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Alnylam Pharmaceuticals INC. | $72.15 | 2023-2025 | Onpattro |
| Angiodynamics, INC. | $65.69 | 2019 | |
| Edwards Lifesciences Corporation | $59.98 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Arbor Pharmaceuticals, INC. | $57.10 | 2019-2022 | |
| Cvrx, INC. | $51.07 | 2023-2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $48.89 | 2023 | |
| Glaxosmithkline, LLC. | $47.48 | 2025 | Shingrix, Arexvy |
| Kestra Medical Technology Services, INC. | $43.92 | 2024-2025 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $41.98 | 2019-2022 | |
| Cagent Vascular INC | $38.09 | 2025 | Serrantor |
| Azurity Pharmaceuticals, INC. | $36.49 | 2024 | Edarbi |
| American Regent | $29.31 | 2023 | Injectafer |
| Genzyme Corporation | $29.16 | 2024 | |
| Althera Pharmaceuticals LLC | $22.22 | 2021 | |
| Agepha Pharma Fz LLC | $21.23 | 2024 | Lodoco |
| Medtronic Vascular, INC. | $20.87 | 2019 | |
| Ge Healthcare | $19.34 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $18.67 | 2023 | Arcalyst |
| Infobionic, INC | $17.20 | 2022 | |
| Inspire Medical Systems, INC. | $17.06 | 2023 | Inspire |
| Preventice Services, LLC | $14.55 | 2021 | |
| Bardy Diagnostics, INC. | $14.00 | 2022 | |
| Tactile Systems Technology INC | $13.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toussaint Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.